ADMA ADMA Biologics Inc

$14.66

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/6/2025

About ADMA Biologics Inc

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures and markets plasma-derived biological products specialized for the treatment of immunodeficiencies and infectious diseases in the United States. The company is headquartered in Ramsey, New Jersey.

Website: https://www.admabiologics.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1368514
Address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, US
Valuation
Market Cap
$5.08B
P/E Ratio
26.31
PEG Ratio
0.00
Price to Book
14.57
Performance
EPS
$0.81
Dividend Yield
—
Profit Margin
46.40%
ROE
81.60%
Technicals
50D MA
$18.09
200D MA
$17.41
52W High
$23.64
52W Low
$6.19
Fundamentals
Shares Outstanding
239M
Target Price
$25.74
Beta
0.53

ADMA EPS Estimates vs Actual

● Estimated
● Actual

ADMA News & Sentiment

Oct 01, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Why Adma Biologics ( ADMA ) Outpaced the Stock Market Today
Adma Biologics (ADMA) concluded the recent trading session at $15.05, signifying a +2.66% move from its prior day's close.
Sep 26, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Is It Worth Investing in Adma Biologics ( ADMA ) Based on Wall Street's Bullish Views?
The average brokerage recommendation (ABR) for Adma Biologics (ADMA) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Sep 25, 2025 • Zacks Commentary NEUTRAL
Adma Biologics ( ADMA ) Declines More Than Market: Some Information for Investors
In the latest trading session, Adma Biologics (ADMA) closed at $15.32, marking a -2.17% move from the previous day.
Sep 25, 2025 • Zacks Commentary NEUTRAL
Are Options Traders Betting on a Big Move in ADMA Biologics Stock?
Investors need to pay close attention to ADMA stock based on the movements in the options market lately.
Sep 19, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Adma Biologics ( ADMA ) Stock Dips While Market Gains: Key Facts
In the latest trading session, Adma Biologics (ADMA) closed at $15.91, marking a -1.55% move from the previous day.
Sep 15, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Adma Biologics ( ADMA ) Stock Drops Despite Market Gains: Important Facts to Note
Adma Biologics (ADMA) closed the most recent trading day at $15.3, moving 5.03% from the previous trading session.
Sentiment Snapshot

Average Sentiment Score:

0.205
50 articles with scored sentiment

Overall Sentiment:

Bullish

ADMA Reported Earnings

Feb 26, 2025
Dec 31, 2024 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.14
  • Estimate: $0.14
  • Whisper: —
  • Surprise %: -6.2%
Nov 07, 2024
Sep 30, 2024 (Post market)
0.02 Surprise
  • Reported EPS: $0.15
  • Estimate: $0.13
  • Whisper: —
  • Surprise %: 15.4%
Aug 08, 2024
Jun 30, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $0.13
  • Estimate: $0.08
  • Whisper: —
  • Surprise %: 62.5%
May 09, 2024
Mar 31, 2024 (Post market)
0.02 Surprise
  • Reported EPS: $0.08
  • Estimate: $0.06
  • Whisper: —
  • Surprise %: 33.3%
Feb 28, 2024
Dec 31, 2023 (Post market)
-0.11 Surprise
  • Reported EPS: $-0.08
  • Estimate: $0.03
  • Whisper: —
  • Surprise %: -366.7%
Nov 08, 2023
Sep 30, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $0.01
  • Estimate: $-0.01
  • Whisper: —
  • Surprise %: 200.0%
Aug 09, 2023
Jun 30, 2023 (Post market)
-0.01 Surprise
  • Reported EPS: $-0.03
  • Estimate: $-0.02
  • Whisper: —
  • Surprise %: -50.0%
May 10, 2023
Mar 31, 2023 (Post market)
0.01 Surprise
  • Reported EPS: $-0.03
  • Estimate: $-0.04
  • Whisper: —
  • Surprise %: 25.0%
Mar 23, 2023
Dec 31, 2022 (Post market)
0.0 Surprise
  • Reported EPS: $-0.06
  • Estimate: $-0.06
  • Whisper: —
  • Surprise %: 0.0%

Financials